Genomic characteristics associated with clinical activity of rucaparib in patients (pts) with BRCA1 or BRCA2 (BRCA)-mutated metastatic castration-resistant prostate cancer (mCRPC) Meeting Abstract
| Authors: | Abida, W.; Campbell, D.; Patnaik, A.; Sautois, B.; Shapiro, J. D.; Vogelzang, N. J.; Bryce, A. H.; McDermott, R. S.; Ricci, F.; Rowe, J. H.; Zhang, J.; Loehr, A.; Despain, D.; Dowson, M.; Golsorkhi, T.; Chowdhury, S. |
| Abstract Title: | Genomic characteristics associated with clinical activity of rucaparib in patients (pts) with BRCA1 or BRCA2 (BRCA)-mutated metastatic castration-resistant prostate cancer (mCRPC) |
| Meeting Title: | 2020 Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 6 Suppl. |
| Meeting Dates: | 2020 Feb 13-15 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-02-20 |
| Language: | English |
| ACCESSION: | WOS:000529525900247 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.6_suppl.178 |
| Notes: | Meeting Abstract: 178 -- Source: Wos |
